ENTR Trademark

Trademark Overview


On Tuesday, December 20, 2022, a trademark application was filed for ENTR with the United States Patent and Trademark Office. The USPTO has given the ENTR trademark a serial number of 79362246. The federal status of this trademark filing is REGISTERED as of Tuesday, November 12, 2024. This trademark is owned by STEMON Inc.. The ENTR trademark is filed in the Pharmaceutical Products category with the following description:

Exosomes for medical use; biological preparations for the treatment of Inflammatory diseases, Regenerative disease, Infectious disease, Immune-related diseases, Respiratory disease, Ocular disease, Cancer, Metastatic disease, Cardiovascular disease, Neurodegenerative disease, and Metabolic disease for human or veterinary purposes; living cells for medical purposes; Pharmaceutical preparations for treatment of Inflammatory diseases, Regenerative disease, Infectious disease, Immune-related diseases, Respiratory disease, Ocular disease, Cancer, Metastatic disease, Cardiovascular disease, Neurodegenerative disease, and Metabolic disease; stem cells for medical purposes; Medicated creams for treating dermatological conditions; Medicated skincare preparations, namely, creams, lotions, gels, toners, cleaners and peels; Colostral antibodies for medical purposes; Medicated dermatological preparations and substances for skin renewal
entr

General Information


Serial Number79362246
Word MarkENTR
Filing DateTuesday, December 20, 2022
Status700 - REGISTERED
Status DateTuesday, November 12, 2024
Registration Number7561380
Registration DateTuesday, November 12, 2024
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 28, 2024

Trademark Statements


Goods and ServicesExosomes for medical use; biological preparations for the treatment of Inflammatory diseases, Regenerative disease, Infectious disease, Immune-related diseases, Respiratory disease, Ocular disease, Cancer, Metastatic disease, Cardiovascular disease, Neurodegenerative disease, and Metabolic disease for human or veterinary purposes; living cells for medical purposes; Pharmaceutical preparations for treatment of Inflammatory diseases, Regenerative disease, Infectious disease, Immune-related diseases, Respiratory disease, Ocular disease, Cancer, Metastatic disease, Cardiovascular disease, Neurodegenerative disease, and Metabolic disease; stem cells for medical purposes; Medicated creams for treating dermatological conditions; Medicated skincare preparations, namely, creams, lotions, gels, toners, cleaners and peels; Colostral antibodies for medical purposes; Medicated dermatological preparations and substances for skin renewal

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSTEMON Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameSTEMON Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameSTEMON Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, February 9, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 23, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 25, 2023REFUSAL PROCESSED BY IB
Tuesday, March 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 14, 2023APPLICATION FILING RECEIPT MAILED
Thursday, September 21, 2023ASSIGNED TO EXAMINER
Friday, September 22, 2023NON-FINAL ACTION WRITTEN
Wednesday, October 4, 2023REFUSAL PROCESSED BY MPU
Wednesday, October 4, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 24, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, March 28, 2024FINAL REFUSAL WRITTEN
Thursday, March 28, 2024FINAL REFUSAL E-MAILED
Thursday, March 28, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, April 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 8, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 28, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, July 12, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, August 3, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sunday, October 6, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, November 12, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 25, 2024EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, July 12, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, November 12, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, February 12, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, April 11, 2025FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 11, 2025FINAL DISPOSITION PROCESSED
Saturday, May 3, 2025FINAL DECISION TRANSACTION PROCESSED BY IB